Searched for
ASTRAZENECA OXFORD
AstraZeneca jab uncertainty will hit Oxford BioMedica’s revenueIn a recent report, Oxford Biomedica warned that uncertainty surrounding AstraZeneca’s Covid-19 contract will bring reduction in earnings t...20 Apr, 2022, 10.05 PM IST- AstraZeneca hits snag in Covid drug developmentThe drug, made from a combination of two antibodies, failed its main goal to treat Covid-19 symptoms in exposed patients, AstraZeneca said ...15 Jun, 2021, 05.12 PM IST
- EU regulator advices against second AstraZeneca shot in those with blood clotsThe advice for healthcare professionals was provided by the European Medicines Agency (EMA) as part of an ongoing review into rare, but sev...21 May, 2021, 06.59 PM IST
- Two AstraZeneca COVID shots could be 85-90% effective, UK real-world data suggestPHE said the preliminary findings were the first of its kind on the effectiveness of two doses of AstraZeneca in a real-world setting but c...20 May, 2021, 10.53 PM IST
- UK scientists find higher risk of brain clots from COVID-19 compared with vaccinesA study of 500,000 COVID-19 patients found CVST had occurred at a rate of 39 people out of a million following infection, researchers said....15 Apr, 2021, 05.22 PM IST
- Sri Lanka temporarily suspends COVID-19 jabs due to delay in securing vaccines from SII: MinisterSri Lanka launched its inoculation programme in late January when India gifted 500,000 doses of Oxford-AstraZeneca. Till Thursday 913,219 p...02 Apr, 2021, 11.53 AM IST
- SII seeks Government's nod to give 50 lakh Covishield doses to UK, says won't affect India's vaccination driveIn a communique to Union Health Secretary Rajesh Bhushan on Tuesday, the Director of Government and Regulatory Affairs at the Pune-based Se...23 Mar, 2021, 08.32 PM IST
- AstraZeneca has sold its stake in Moderna for more than $1 billion: The TimesAstraZeneca is retaining partnership with Moderna on other disease treatments and could sell its AstraZeneca/Oxford University COVID-19 vac...01 Mar, 2021, 09.39 AM IST
- AstraZeneca, Oxford expect 'next generation' COVID-19 vaccine to tackle variants by autumn - executiveAsked when AstraZeneca could produce a next generation vaccine to tackle new variants, AstraZeneca research chief Mene Pangalos said "as ra...03 Feb, 2021, 05.31 PM IST
- Britain approves AstraZeneca/Oxford COVID-19 vaccineRegulatory endorsement is a welcome boost for AstraZeneca and the Oxford team, which have been accused of a lack of clarity about the resul...30 Dec, 2020, 01.21 PM IST
- 2020's parting shot: India to roll out COVID-19 vaccine in January"India is a part of 'COVAX'. We will keep giving 50 per cent of everything we make to India and to COVAX at the same time. India has such a...29 Dec, 2020, 06.58 AM IST
- After varied efficacy data, AstraZeneca to conduct fresh clinical trials of COVID-19 vaccineAstraZeneca/Oxford said this week it would assess why its vaccine candidate generated better efficacy at a lower dose. The statement came a...27 Nov, 2020, 07.01 AM IST
- AstraZeneca-Oxford vaccine safe, Indian trials progressing smoothly: Serum InstituteVaccine major Serum Institute of India on Thursday said the Covid-19 vaccine developed by AstraZeneca and Oxford University is safe and eff...26 Nov, 2020, 09.12 PM IST
- Will resume COVID-19 vaccine trials after DCGI nod: Serum InstitutePharma giant AstraZeneca on Saturday said that clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the...12 Sep, 2020, 10.08 PM IST
- Oxford, AstraZeneca COVID-19 vaccine trials resume days after pauseThe study had been previously stopped in July for several days after a participant who got the vaccine developed neurological symptoms; it ...12 Sep, 2020, 09.01 PM IST
- Serum Institute of India officially halts the trial of Astrazeneca-Oxford vaccine in India"We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We are following DCGI's instructions and wil...11 Sep, 2020, 06.54 AM IST
- India trials of COVID-19 vaccine is going on: Serum InstituteLast month, the Drug Controller General of India had granted permission to the Pune-based SII to conduct Phase-II and -III human clinical t...10 Sep, 2020, 12.08 PM IST
Load More
